$121.1 Million In Cash and Cash Equivalents at December 31, 2023, With an Additional $21.8 Million Raised In 2024 From Exercise of Warrants.A Total of Over.
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Individuals living with HIV must adhere to lifelong antiretroviral therapy to prevent the virus from multiplying within the body. However, some individuals, known as.
Cassava Sciences: How To Interpret 3 Positive Updates Shared In Q3 (NASDAQ:SAVA) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.